WCM
PRAX icon

Wildcat Capital Management’s Praxis Precision Medicines PRAX Stock Holding History

Wildcat Capital Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-16,756
Closed -$373K – 20
2023
Q4 		$373K Buy
+16,756
New +$302K 0.13% 16

Other funds holding PRAX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Wildcat Capital Management's PRAX Position: Q1 2024 in Review

Wildcat Capital Management sold out of Praxis Precision Medicines (PRAX) in Q1 2024, closing a stake of 16,756 shares — an estimated $373K sold.

Wildcat Capital Management first reported a position in PRAX in Q4 2023 and held it in 1 quarter. The position peaked at $373K in Q4 2023. 111 funds tracked by Wall St. Rank hold PRAX as of Q1 2024.

  • Wildcat Capital Management reported no remaining Praxis Precision Medicines position as of Q1 2024 after selling out during the quarter.
  • Wildcat Capital Management sold 16,756 Praxis Precision Medicines shares in Q1 2024, an estimated $373K.
  • Wildcat Capital Management first reported a position in Praxis Precision Medicines in Q4 2023 and held it in 1 quarter.
  • Wildcat Capital Management's Praxis Precision Medicines position peaked at $373K in Q4 2023.
  • 111 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2024.

Based on Wildcat Capital Management's 13F filing for Q1 2024, filed 14 May 2024.